IBM Commits $150 Billion To U.S. Investment In Enterprise Tech And Quantum Computing

IBM announced plans to invest $150 billion in the United States over the next five years, including more than $30 billion dedicated to advancing mainframe and quantum computing research. The tech giant says the move will drive economic growth and strengthen its position as a global leader in computing and AI innovation. CEO Arvind Krishna emphasized IBM’s long-standing commitment to American jobs and manufacturing, stating that the company—founded 114 years ago—will continue to serve as the epicenter of cutting-edge technological capabilities. IBM’s announcement comes amid a broader wave of enterprise tech companies investing heavily in U.S. manufacturing and infrastructure, a trend that has accelerated over the past several years. AMOUNT: $150,000,000,000 committed over five years SECTORS: Enterprise Tech / Quantum Computing / AI / Manufacturing CEO: Arvind Krishna #TradedVC #IBM #QuantumComputing #AI #EnterpriseTech #Manufacturing #VentureCapital #StartupNews #PublicMarkets #TechInvestments

More Deals

View All

Colossal Biosciences In Talks For Funding Round Targeting $23 Billion ValuationColossal Biosciences, the de-extinction biotech startup known for its efforts to recreate the woolly mammoth and other extinct species, is reportedly in talks to raise new funding at a valuation of roughly $23 billion–$24 billion, according to Axios. The potential raise would mark a significant jump for the five-year-old company, with investors valuing not only its genetic-engineering programs but also its broader genomics, reproductive technology, conservation, and intellectual property platform. Colossal has begun generating revenue through conservation technology sales and technology spinouts, including Astromech, an AI-driven predictive modeling company, and Form Bio, a computational biology platform, expanding its value beyond de-extinction efforts. FOUNDERS: Ben Lamm & George Church TARGET VALUATION: $23,000,000,000 HQ: Dallas, Texas #VentureCapital #ColossalBiosciences #BenLamm #GeorgeChurch #TradedVC